{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:25:17Z","timestamp":1794684317280,"version":"4.9.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.euo.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:04:56Z","timestamp":1639065896000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors"],"prefix":"10.1016","volume":"5","author":[{"given":"Chiara","family":"Lonati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"G\u00f3mez Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Afferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Ventimiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2021.11.001_b0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch Task Force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euo.2021.11.001_b0010","doi-asserted-by":"crossref","first-page":"648","DOI":"10.21037\/tau.2016.03.18","article-title":"Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma\u202f: its clinical impact","volume":"5","author":"Colin","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0015","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum","volume":"54","author":"Roupr\u00eat","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.juro.2015.02.081","article-title":"Lynch syndrome: a primer for urologists and panel recommendations","volume":"194","author":"Mork","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2021.11.001_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194039","article-title":"Smoking intensity and bladder cancer aggressiveness at diagnosis","volume":"13","author":"Barbosa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2021.11.001_b0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(01)62926-4","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23508","article-title":"The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome","volume":"123","author":"Watson","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0045","first-page":"6796","article-title":"Frequent microsatellite instability in sporadic tumors of the upper urinary tract","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2021.11.001_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/iju.13481","article-title":"Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening","volume":"25","author":"Urakami","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0055","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumours of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.euo.2021.11.001_b0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jjco\/hyz140","article-title":"Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population","volume":"50","author":"Ito","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euo.2021.11.001_b0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1309\/AJCPBSLP8XHSWLOW","article-title":"Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma","volume":"139","author":"Bai","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-5-23","article-title":"Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma","volume":"5","author":"Ericson","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/hupa.2003.22","article-title":"Urothelial carcinoma of the upper urinary tract: Inverted growth pattern is predictive of microsatellite instability","volume":"34","author":"Hartmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0080","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1007\/s13277-014-2141-4","article-title":"Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis","volume":"35","author":"Ehsani","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.euo.2021.11.001_b0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/modpathol.2016.171","article-title":"Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndrome","volume":"30","author":"Harper","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","article-title":"Universal Lynch syndrome screening should be performed in all upper tract urothelial carcinomas","volume":"42","author":"Ju","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0095","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with lynch syndrome","volume":"30","author":"Engel","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2021.11.001_b0100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ajcp\/aqaa100","article-title":"Universal mismatch repair protein screening in upper tract urothelial carcinoma: a validation study with comparison to colorectal and endometrial adenocarcinoma","volume":"154","author":"Gayhart","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0105","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/j.clgc.2020.03.006","article-title":"Loss of mismatch-repair protein expression and microsatellite instability in upper tract urothelial carcinoma and clinicopathologic implications","volume":"18","author":"Schneider","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-020-02745-4","article-title":"Clinicopathologic analysis of upper urinary tract carcinoma with variant histology","volume":"477","author":"Rolim","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euo.2021.11.001_b0115","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10689-012-9526-6","article-title":"Uroepithelial and kidney carcinoma in Lynch syndrome","volume":"11","author":"Aarnio","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2012.07.047","article-title":"Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer","volume":"63","author":"Skeldon","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bju.12008","article-title":"Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer syndrome)","volume":"112","author":"Hubosky","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0135","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/1878-0261.12325","article-title":"Molecular subtype classification of urothelial carcinoma in Lynch syndrome","volume":"12","author":"Therkildsen","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.euo.2021.11.001_b0140","article-title":"Genomic characterization of upper-tract urothelial carcinoma in patients with Lynch syndrome","volume":"2018","author":"Donahue","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2021.11.001_b0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for Lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0150","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.urology.2015.08.018","article-title":"Urinary tract cancer in Lynch syndrome; increased risk in carriers of MSH2 mutations","volume":"86","author":"Joost","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.euo.2021.11.001_b0155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.MP.0000024263.25043.0C","article-title":"Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis","volume":"15","author":"Blaszyk","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euo.2021.11.001_b0160","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.onc.1209229","article-title":"Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract","volume":"25","author":"Mongiat-Artus","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.euo.2021.11.001_b0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","article-title":"Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma","volume":"65","author":"Roupr\u00eat","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.euo.2021.11.001_b0170","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.ju.0000086551.22844.cd","article-title":"Microsatellite instability in urothelial carcinoma of the upper urinary tract","volume":"170","author":"Amira","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11684-019-0687-7","article-title":"Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma","volume":"13","author":"Wang","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.euo.2021.11.001_b0180","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1053\/gast.1996.v110.pm8612988","article-title":"Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis","volume":"110","author":"Vasen","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euo.2021.11.001_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-012-9573-z","article-title":"The spectrum of urological malignancy in Lynch syndrome","volume":"12","author":"Barrow","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2003.017871","article-title":"Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma","volume":"41","author":"Roupr\u00eat","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.euo.2021.11.001_b0195","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1111\/j.1464-410X.2012.11298.x","article-title":"A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool","volume":"110","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1464-410X.2005.05585.x","article-title":"Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma","volume":"96","author":"Roupr\u00eat","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0205","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bju.12308","article-title":"Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours","volume":"113","author":"Hollande","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1464-410X.2010.09443.x","article-title":"Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma","volume":"106","author":"Acher","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10689-008-9193-9","article-title":"Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer","volume":"7","author":"Myrh\u00f8j","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00365599.2011.599334","article-title":"Urinary tract cancer in patients with hereditary non-polyposis colorectal cancer","volume":"46","author":"Zachhau","year":"2012","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euo.2021.11.001_b0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1464-410X.2005.05671.x","article-title":"Microsatellite instability and transitional cell carcinoma of the upper urinary tract","volume":"96","author":"Roupr\u00eat","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2021.11.001_b0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOU.0000000000000340","article-title":"Lynch syndrome in upper tract urothelial carcinoma: Significance, screening, and surveillance","volume":"27","author":"Pradere","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0235","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care predisposition to Lynch syndrome","volume":"296","author":"Lindor","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2021.11.001_b0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2021.11.001_b0245","first-page":"80","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"9","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2021.11.001_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21510","article-title":"Molecular testing for Lynch syndrome in people with colorectal cancer: Systematic reviews and economic evaluation","volume":"21","author":"Snowsill","year":"2017","journal-title":"Health Technol Assess (Rockv)"},{"key":"10.1016\/j.euo.2021.11.001_b0255","first-page":"249","article-title":"A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"59","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2021.11.001_b0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1155\/2004\/159347","article-title":"Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis","volume":"20","author":"Buhard","year":"2004","journal-title":"Dis Markers"},{"key":"10.1016\/j.euo.2021.11.001_b0265","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.euo.2021.11.001_b0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":"EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.euo.2021.11.001_b0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2021.11.001_b0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","article-title":"Strategies to identify the Lynch syndrome among patients with colorectal cancer","volume":"155","author":"Ladabaum","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euo.2021.11.001_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1254-5","article-title":"A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients","volume":"15","author":"Snowsill","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2021.11.001_b0290","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.euo.2021.11.001_b0295","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2021.11.001_b0300","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2021.11.001_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13143505","article-title":"Endoscopy to diagnose and prevent digestive cancers in lynch syndrome","volume":"13","author":"Olivier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2021.11.001_b0310","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2021.11.001_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair\u2013deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931121001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:17Z","timestamp":1762876097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931121001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2588931121001899"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2021.11.001","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}